Skip to Content Skip to Content

Coronavirus

Reminders to stay cautious aren’t the biggest reasons for COVID-19 vaccine hesitancy

Reminders to stay cautious aren’t the biggest reasons for COVID-19 vaccine hesitancy

Melanie Kornides of the School of Nursing said cautious messaging around the COVID-19 vaccine isn’t a major factor in vaccine hesitancy. “We’ve been seeing all along, even before the vaccine came out, that they’re worried about long term safety, that they’re worried that the process was rushed, and that there are political motivations for not wanting to be vaccinated,” she said. “Those continue to be the large majority of the concerns.”

We still don’t know how well COVID vaccines stop transmission

We still don’t know how well COVID vaccines stop transmission

Scott Halpern of the Perelman School of Medicine weighed in on two new studies, neither of which have been peer reviewed yet, that claim the COVID-19 vaccine can suppress transmission rates. “Once you’ve been bombarded with bad news long enough, any glimmer of good news is something we just emotionally latch onto,” said Halpern. “That’s just human nature.”

FDA review confirms safety and efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases

FDA review confirms safety and efficacy of single-shot Johnson & Johnson coronavirus vaccine, especially against severe cases

E. John Wherry of the Perelman School of Medicine said people should disregard detractors and take whichever approved COVID-19 vaccine they can get. “We have a really important job to do on how we message this,” he said. “The day that an individual has a choice on which vaccine to get—that’s a great day, but probably won’t be until summer.”

COVID-19 vaccine makers consider adapting vaccines, booster shots against resistant variants

COVID-19 vaccine makers consider adapting vaccines, booster shots against resistant variants

Drew Weissman of the Perelman School of Medicine spoke about adapting COVID-19 vaccines for new variants, which would not require new clinical trials. “We’ve been doing this with flu for many years,” he said. “The variants aren’t that different.”

Race versus time: Targeting vaccine to the most vulnerable is no speedy task

Race versus time: Targeting vaccine to the most vulnerable is no speedy task

Harald Schmidt of the Perelman School of Medicine said that the U.S. has an opportunity to prove that it’s invested in repairing longstanding health disparities through the COVID-19 vaccine rollout process. “The longer-term implication of how we dealt with social justice will be very powerful—so we do have to get this right,” he said.

Finding beauty in everything, through a camera lens
The underside of a bridge, with blue, purple, and teal greens visible.

Finding beauty in everything, through a camera lens

Karen Reivich of Penn’s Positive Psychology Center turned to photography to reconnect to herself during the pandemic. It helped her discover a new way of seeing the world.

Michele W. Berger